Obesity and Diabetes
Results From Phase 3 EQUATE Trial of VIVUS' Qnexa Highlighted at European Congress on Obesity
Published in Obesity and Diabetes Week, May 18th, 2009
VIVUS, Inc. (NASDAQ:VVUS), a biopharmaceutical company dedicated to the development and commercialization of novel therapeutic products, announced that data from the previously reported 28-week phase 3 EQUATE trial of Qnexa(TM) in obese patients are being presented today at the 17th annual European Congress on Obesity (ECO) in Amsterdam, The Netherlands. The results, titled "Weight Loss at 6 Months with VI-0521 Treatment," will be presented at the Hot Topic poster session by Donna H. Ryan, M.D., Associate Executive Director for Clinical Research, Pennington Biomedical Research Center in Baton Rouge, LA. The presentation marks the first time these results have been shared with the medical...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
More Articles from Obesity and Diabetes Week
- American Gastroenterological Association
Calorie restriction causes temporal changes in liver metabolism - Elsevier Health Sciences
People of higher socioeconomic status choose better diets -- but pay more per calorie - NIH/National Institute of Environmental Health Sciences
New data analysis shows possible link between childhood obesity and allergies - Adipose Tissue
New adipose tissue study findings recently were published by researchers at Kagawa University, Medical Department - Aging
New research on aging from Washington University summarized - Alzheimer Disease
Latinos in Chicago and Suburbs Face Alarming Numbers of Cases of Alzheimer's Disease While Thousands More are at Risk of Being Diagnosed - More from this issue of Obesity and Diabetes Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
